Investment Focus

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies.

The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. Companies raising growth capital for product commercialization or developing therapeutic products for indications with high unmet medical need are of particular interest.

Thomas, McNerney & Partners invests in companies at all stages of their development. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.

The firm has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast. Situated in three hotbeds of life science and medical technology innovation, the Thomas, McNerney & Partners team has broad geographical reach and the ability to provide portfolio companies with local support as well as access to multiple networks.